Comparison

iURO Oncology vs ASCO Guidelines

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

iURO Oncology

This app provides narrated simulation videos and interactive 3D models to explain uro-oncology conditions and treatments. It's designed for healthcare professionals, students, and patients to enhance understanding and communication.

Highlights
  • Narrated simulation videos for cancers
  • Explanation of treatment options
  • Interactive 3D image drawing and notes
  • 360º view of kidney anatomy
  • Email sharing of customized images
Features
Read full description

iURO Oncology is the must-have app for all uro-oncology healthcare professionals and students. The narrated simulation videos make it easy to understand and explain the different pathologies and therapies. It can be used by doctors and nurses to enhance communication with their patients. Medical students can use iURO apps to increase their knowledge and understanding of various urological and oncological topics. iURO Oncology can also be used by patients directly, to familiarize themselves with the different aspects of their oncological condition and the treatment options available. Features include: •Narrated simulation videos to explain prostate cancer, kidney cancer, bladder cancer and testicular cancer •Narrated simulation videos to explain different treatment options •Draw on picture, offering the opportunity to draw on and make personalized notes on a 3D image •Send this customized 3D image directly to patients or colleagues by email •360º image of the kidney, offering the opportunity to zoom on the 3D image from every angle iURO apps are created in consultation with urologists in order to provide a realistic representation of pathologies and therapies. iURO apps are prepared with the aim of enhancing communication and education options. If you are not a healthcare professional, please note that iURO apps support but never substitute the relation with your healthcare professional. App Management: •Scientific Director: Carlos Rioja, Hospital Royo Villanova, Zaragoza, Spain •Scientific Director: Jorge Rioja, Hospital Miguel Servet, Zaragoza, Spain •Scientific Director: Sanjeev Bandi, Mackay Urology, Mackay Australia iURO Scientific Advisory Board: Lithiasis •Olivier Traxer, University Pierre et Marie Curie Paris, France •Adrian Joyce, Spire Leeds Hospital in Roundhay, Leeds, Yorkshire, United Kingdom Benign Prostatic Hyperplasia •Jean de la Rosette, AMC University Hospital, Amsterdam, The Netherlands •Matthias Oelke, Hanover Medical School, Hanover, Germany Pelvic Floor Disorder, Functional and Female Urology •David Castro, University of La Laguna, Tenerife, Spain •Dirk De Ridder, Kliniekhoofd Urologie UZ, Leuven, Belgium Oncology •Karim Touijer, Memorial Sloan Kettering Cancer Center, New York, USA •Raul Parra, Memorial Sloan Kettering Cancer Center, New York, USA •Peter Scardino, Memorial Sloan Kettering Cancer Center, New York, USA •Pilar Laguna, AMC University Hospital, Amsterdam •Sharokh Shariat, Weill Medical College of Cornell University, New York, USA •Theo de Reijke, AMC University Hospital Amsterdam, The Netherlands •Octavio Castillo Cadiz, Clínica Indisa, Santiago, Chile •Jaime Landman, University of California Irvine, Los Angeles, USA Andrology •Eduard Garcia, University Hospital Clícic de Barcelona, Barcelona, Spain •Juan Ignacio Martinez Salamanca, University Hospital Puerta de Hierro Majadahonda, Autonomous University of Madrid, Madrid, Spain •Ignacio Moncada, Hospital La Zarzuela, Madrid, Spain •David J Ralph, St Peter’s Andrology Centre, London, United Kingdom •Nelson Bennett, Lahey Hospital and Medical Center, Burlington, USA •Rados Djinovic, Sava Perovic Foundation, Belgrade, Serbia

About

ASCO Guidelines

Access comprehensive cancer care guidelines and interactive tools to inform treatment decisions. This app supports healthcare providers, patients, and caregivers in implementing recommended cancer care options for various cancer types, aiming to improve the quality of care.

Highlights
  • Guideline recommendations for cancer care
  • Interactive treatment decision tools
  • Supports healthcare providers
  • Informs patients and caregivers
  • Covers various cancer types
  • Regularly updated content
Features
Read full description

The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.

Screenshots

iURO Oncology4 screens
ASCO Guidelines4 screens

Verdict

The call

The clearest difference is review sentiment: ASCO Guidelines at 57% against iURO Oncology's 0%. ASCO Guidelines also leads on rating (4.8 vs 1.0) and ratings volume (265 vs 1). iURO Oncology's advantage is update cadence (every 2 months vs every 5 months) and iOS requirement (8.1 vs 10.0). On price, ads, in-app purchases and monetization model there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

ASCO Guidelines holds the better App Store score, 4.8 against 1.0. That said, the two scores are not equally well evidenced: ASCO Guidelines has 265 ratings behind it against 1, so its average is the more settled of the two. Written reviews point the same way: 0% of iURO Oncology's written reviews are positive against 57% of ASCO Guidelines's.

UpkeepUpdate frequency

iURO Oncology ships an update every 2 months, ASCO Guidelines every 5 months. The most recent releases landed on November 6, 2026 and November 13, 2026 respectively.

Scorecard5 real differences · 5 level
iURO Oncology versus ASCO Guidelines: the parameters behind the verdict, then further details
ParameteriURO OncologyASCO Guidelines
PriceFreeFree
Rating1.0 (1 ratings)4.8 (265 ratings) — better
Positive reviews0.0% of reviews57.1% of reviews — better
Number of ratings1265 — better
Update frequencyEvery 2 months — betterEvery 5 months
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS8.1 — better10.0
Further details — not scored
Size307 MB411 MB
Age rating17+12+
DeveloperURO DevelopmentsAmerican Society of Clinical Oncology

Customer experience

iURO Oncology

All ratings1 ratings
Positive0.0%
Neutral0.0%
Negative100.0%
Written reviews6 reviews
Positive0.0%
Neutral0.0%
Negative100.0%

ASCO Guidelines

All ratings257 ratings
Positive95.3%
Neutral1.6%
Negative3.1%
Written reviews7 reviews
Positive57.1%
Neutral0.0%
Negative42.9%

In-app purchases

None

iURO Oncology

No in-app purchases

None

ASCO Guidelines

No in-app purchases

Questions

Is iURO Oncology free?
iURO Oncology is free to download, with no in-app purchases.
Is ASCO Guidelines free?
ASCO Guidelines is free to download, with no in-app purchases.
Which has better reviews, iURO Oncology or ASCO Guidelines?
ASCO Guidelines is rated higher. iURO Oncology averages 1.0 out of 5 from 1 ratings, while ASCO Guidelines averages 4.8 from 265 ratings.
Do iURO Oncology or ASCO Guidelines have ads?
Neither iURO Oncology nor ASCO Guidelines shows ads.
Which is updated more often, iURO Oncology or ASCO Guidelines?
iURO Oncology ships an update every 2 months, and ASCO Guidelines every 5 months. Most recently, iURO Oncology was updated on November 6, 2026 and ASCO Guidelines on November 13, 2026.

Other comparisons